Genetics and research company 23andMe is merging with Virgin Group’s VG Acquisition Corp. The merger, with a balance of more than $900 million for the combined company, will provide capital funding to grow 23andMe’s initiatives. CEO and Co-Founder Anne Wojcicki said it presents an opportunity to personalize consumers’ experiences, “allowing individuals to be more proactive about their health and wellness. Through a genetics-based approach, we fundamentally believe we can transform the continuum of healthcare.”